| MeSH term | MeSH ID | Detail |
|---|---|---|
| Hypertension | D006973 | 115 associated lipids |
| Hypertension, Pulmonary | D006976 | 32 associated lipids |
| Insulin Resistance | D007333 | 99 associated lipids |
| Hypertrophy, Right Ventricular | D017380 | 4 associated lipids |
Total
4
14,15-dihetre
14,15-dihetre is a lipid of Fatty Acyls (FA) class.
Cross Reference
There are no associated biomedical information in the current reference collection.
Current reference collection contains 204 references associated with 14,15-dihetre in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.
Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.
Here are additional resources we collected from PubChem and MeSH for 14,15-dihetre
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with 14,15-dihetre
PubChem Biomolecular Interactions and Pathways
NCBI Entrez Crosslinks
All references with 14,15-dihetre
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Ghosh S et al. | Oral delivery of 1,3-dicyclohexylurea nanosuspension enhances exposure and lowers blood pressure in hypertensive rats. | 2008 | Basic Clin. Pharmacol. Toxicol. | pmid:18312493 |
| Zhang W et al. | Role of soluble epoxide hydrolase in the sex-specific vascular response to cerebral ischemia. | 2009 | J. Cereb. Blood Flow Metab. | pmid:19471280 |
| Shen HC et al. | Discovery of 3,3-disubstituted piperidine-derived trisubstituted ureas as highly potent soluble epoxide hydrolase inhibitors. | 2009 | Bioorg. Med. Chem. Lett. | pmid:19682899 |
| Xiao B et al. | Overexpression of cytochrome P450 epoxygenases prevents development of hypertension in spontaneously hypertensive rats by enhancing atrial natriuretic peptide. | 2010 | J. Pharmacol. Exp. Ther. | pmid:20501636 |
| Zheng C et al. | Gene delivery of cytochrome p450 epoxygenase ameliorates monocrotaline-induced pulmonary artery hypertension in rats. | 2010 | Am. J. Respir. Cell Mol. Biol. | pmid:20118222 |
| Xu X et al. | Increased CYP2J3 expression reduces insulin resistance in fructose-treated rats and db/db mice. | 2010 | Diabetes | pmid:20068141 |
| Liu JY et al. | Inhibition of soluble epoxide hydrolase enhances the anti-inflammatory effects of aspirin and 5-lipoxygenase activation protein inhibitor in a murine model. | 2010 | Biochem. Pharmacol. | pmid:19896470 |
| Schebb NH et al. | Development of an online SPE-LC-MS-based assay using endogenous substrate for investigation of soluble epoxide hydrolase (sEH) inhibitors. | 2011 | Anal Bioanal Chem | pmid:21479549 |
| Kopf PG et al. | Angiotensin II regulates adrenal vascular tone through zona glomerulosa cell-derived EETs and DHETs. | 2011 | Hypertension | pmid:21199991 |
| Zhu P et al. | Development of a semi-automated LC/MS/MS method for the simultaneous quantitation of 14,15-epoxyeicosatrienoic acid, 14,15-dihydroxyeicosatrienoic acid, leukotoxin and leukotoxin diol in human plasma as biomarkers of soluble epoxide hydrolase activity in vivo. | 2011 | J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. | pmid:21798825 |